IL230787A0 - Formulations for oral administration containing hyaluronic acid for sustained release of a drug - Google Patents
Formulations for oral administration containing hyaluronic acid for sustained release of a drugInfo
- Publication number
- IL230787A0 IL230787A0 IL230787A IL23078714A IL230787A0 IL 230787 A0 IL230787 A0 IL 230787A0 IL 230787 A IL230787 A IL 230787A IL 23078714 A IL23078714 A IL 23078714A IL 230787 A0 IL230787 A0 IL 230787A0
- Authority
- IL
- Israel
- Prior art keywords
- hyaluronic acid
- drug release
- formulations containing
- oral formulations
- sustained drug
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 229920002674 hyaluronan Polymers 0.000 title 1
- 229960003160 hyaluronic acid Drugs 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000013269 sustained drug release Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11179819 | 2011-09-02 | ||
| PCT/EP2012/066975 WO2013030348A1 (en) | 2011-09-02 | 2012-08-31 | Oral formulations containing hyaluronic acid for sustained drug release |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL230787A0 true IL230787A0 (en) | 2014-03-31 |
Family
ID=46755026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL230787A IL230787A0 (en) | 2011-09-02 | 2014-02-03 | Formulations for oral administration containing hyaluronic acid for sustained release of a drug |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20140302131A1 (enExample) |
| EP (1) | EP2750665A1 (enExample) |
| KR (1) | KR20140058581A (enExample) |
| CN (1) | CN103781473A (enExample) |
| AU (1) | AU2012300815A1 (enExample) |
| CA (1) | CA2847328A1 (enExample) |
| IL (1) | IL230787A0 (enExample) |
| IN (1) | IN2014CN02343A (enExample) |
| WO (1) | WO2013030348A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114767649A (zh) * | 2021-12-22 | 2022-07-22 | 北京佗林医药科技有限公司 | 一种顺式透明质酸六糖的制剂及其制备方法 |
| EP4487834A1 (en) | 2023-07-07 | 2025-01-08 | NuPep AS | Consensus peptides in hya |
| EP4487863A1 (en) | 2023-07-07 | 2025-01-08 | NuPep AS | Consensus peptides in hya for use in treating degenerated joints |
| EP4739277A1 (en) | 2023-07-07 | 2026-05-13 | NuPep AS | Consensus peptides in hya |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60251898A (ja) | 1984-05-25 | 1985-12-12 | Shiseido Co Ltd | 醗酵法によるヒアルロン酸の製造方法 |
| IT1271001B (it) | 1994-07-26 | 1997-05-26 | Poli Ind Chimica Spa | Procedimento di preparazione di acido ialuronico mediante fermentazione con streptococcus |
| WO1997028828A1 (en) | 1996-02-09 | 1997-08-14 | Amgen Boulder Inc. | Composition comprising interleukin-1 inhibitor and controlled release polymer |
| DK0941349T3 (da) | 1996-11-18 | 2004-02-09 | Novozymes Biotech Inc | Fremgangsmåde til fremstilling af polypeptider i surfactinmutanter af Bacillusceller |
| JP4234803B2 (ja) * | 1997-10-27 | 2009-03-04 | 久光製薬株式会社 | 薬物放出速度が制御された医薬組成物 |
| ATE284954T1 (de) | 1997-10-31 | 2005-01-15 | Univ Oklahoma | Hyaluronan synthase gen und seine verwendung |
| CA2326821C (en) | 1998-04-02 | 2010-09-28 | The Board Of Regents Of The University Of Oklahoma | Nucleic acid encoding hyaluronan synthase and methods of use |
| US6444447B1 (en) | 1998-11-11 | 2002-09-03 | The Board Of Regents Of The University Of Oklahoma | Polymer grafting by polysaccharide synthases |
| JP2005525091A (ja) | 2001-12-21 | 2005-08-25 | ノボザイムス バイオポリマー アクティーゼルスカブ | 組換え宿主細胞におけるヒアルロナンの生成方法 |
| WO2003061626A1 (en) | 2002-01-18 | 2003-07-31 | Control Delivery Systems, Inc. | Polymeric gel system for the controlled delivery of codrugs |
| DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
-
2012
- 2012-08-31 WO PCT/EP2012/066975 patent/WO2013030348A1/en not_active Ceased
- 2012-08-31 AU AU2012300815A patent/AU2012300815A1/en not_active Abandoned
- 2012-08-31 EP EP12751545.0A patent/EP2750665A1/en not_active Withdrawn
- 2012-08-31 KR KR1020147005084A patent/KR20140058581A/ko not_active Withdrawn
- 2012-08-31 CA CA2847328A patent/CA2847328A1/en not_active Abandoned
- 2012-08-31 US US14/342,486 patent/US20140302131A1/en not_active Abandoned
- 2012-08-31 CN CN201280042014.9A patent/CN103781473A/zh active Pending
- 2012-08-31 IN IN2343CHN2014 patent/IN2014CN02343A/en unknown
-
2014
- 2014-02-03 IL IL230787A patent/IL230787A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140058581A (ko) | 2014-05-14 |
| CN103781473A (zh) | 2014-05-07 |
| EP2750665A1 (en) | 2014-07-09 |
| AU2012300815A1 (en) | 2014-02-20 |
| CA2847328A1 (en) | 2013-03-07 |
| US20140302131A1 (en) | 2014-10-09 |
| WO2013030348A1 (en) | 2013-03-07 |
| IN2014CN02343A (enExample) | 2015-06-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2629786A4 (en) | COMPOSITIONS FOR THE ADMINISTRATION OF MEDICAMENTS | |
| IL228709A0 (en) | Dosage unit form for oral administration | |
| IL232041A0 (en) | Immediate-release oral formulations for metabolised quinazolinones | |
| HUE042850T2 (hu) | Készítmények hatóanyag szállításra | |
| EP2547333A4 (en) | STABLE BORTEZOMIB FORMULATIONS | |
| ZA201402669B (en) | Solution for oral administration | |
| IL232305B (en) | Pharmacy preparations | |
| EP2665471A2 (en) | Controlled release oral pharmaceutical dosage forms comprising mgbg | |
| EP2582396A4 (en) | REMEDY FORMULATIONS WITH LONG-TERM EFFECT | |
| IL234931A0 (en) | Stable immediate-release oral pharmaceutical preparations containing prasugrel | |
| ZA201308316B (en) | Sustained release paracetamol formulations | |
| GB201110632D0 (en) | Drug delivery formulations | |
| HUE040419T2 (hu) | Analgetikus gyógyászati kompozíció orális beadásra | |
| PT2568970T (pt) | Formulações farmacêuticas estáveis contendo um anti-histamínico | |
| EP2750674A4 (en) | SYSTEMS FOR THE DELIVERY OF THIOCYTIC ACID FROM TEMPORARY RELATED TONGUE | |
| GB201001335D0 (en) | Drug release formulations | |
| GB201111577D0 (en) | Pharmaceutical formulations | |
| GB201005639D0 (en) | Drug delivery formulations | |
| GB201012047D0 (en) | Pharmaceutical formulations | |
| GB201012046D0 (en) | Pharmaceutical formulations |